Navigation Links
Dow Agrosciences licenses exclusive novel crop enhancement technology
Date:11/2/2010

The John Innes Centre is pleased to announce an exclusive commercial license agreement for technology that enhances the root systems of plants and with important implications for crop improvement. JIC's technology management company Plant Bioscience Limited (PBL) is licensing the technology to Dow AgroSciences.

Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), entered into an exclusive commercial license agreement with Plant Bioscience Limited (PBL) for technology that enhances the root systems of plants with important implications for crop improvement. The commercial license covers a range of important agricultural crops.

The technology was developed by Dr. Liam Dolan and his colleagues at the John Innes Centre, an institute of the BBSRC on the Norwich Research Park. With BBSRC funding, the team cloned and characterized genes which may play vital roles in anchorage, water use and nutrient uptake in plants. The genes are highly conserved among land plants and the technology has already been shown to be effective in enhancing root systems in transgenic plants of major crops around the world.

"Our research aims to answer key questions in biology and to provide solutions to important problems in food security, energy production, promoting health and combating disease," said Professor Dale Sanders, Director of the John Innes Centre. "The technology was born out of basic research in nutrient uptake by plants and demonstrates the importance to agriculture of answering fundamental questions."

"Dow AgroSciences is excited to be collaborating with one of the most respected organizations in the biotechnology industry," said Dan Kittle, Ph.D., vice president of Dow AgroSciences. "By combining our expertise in biotech crops and PBL's innovative technology from JIC, we have the opportunity to enhance a plant's ability to survive stress, increase nutrient utilization, and provide yield stability in challenging years or in parts of the world where there are less than favorable growing conditions."

The technology could bring improved crop varieties to the agricultural market and help open new markets.

"We are delighted to enter this partnership with Dow AgroSciences," said Dr Jan Chojecki, Managing Director of PBL. "This technology has real potential to benefit agriculture and address global challenges of food production, and Dow AgroSciences' acknowledged strength in developing and commercializing new crop products is the key to achieving this important goal."

The commercial license covers a range of important agricultural crops.


'/>"/>

Contact: Zoe Dunford
zoe.dunford@bbsrc.ac.uk
44-016-032-55111
Norwich BioScience Institutes
Source:Eurekalert

Related biology news :

1. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
2. UGA licenses invention that kills food-borne pathogens in minutes
3. UGA licenses new Bermuda grass that thrives in sun and shade
4. UGA licenses technology to make fuel from dead forests and agricultural waste
5. MSU licenses plant oil enhancement technology to BASF Plant Science
6. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
7. UT-Battelle licenses tissue regeneration technologies to NellOne Therapeutics, Inc.
8. Virginia Tech licenses GenoCAD source code to ISCB
9. UC Riverside licenses technology to OlFactor Laboratories, Inc.
10. U of M licenses unique plant protection product
11. Brown licenses potential muscular dystrophy treatment to Tivorsan Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology: